Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Not yet recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gynecologic 1

Conditions

Uterine Cervical Neoplasms 2Uterine Cervical Dysplasia 2Papillomavirus Infections 2Infections 1Human Papillomavirus-Related Cervical Carcinoma 1High Grade Anal Canal Intraepithelial Neoplasia 1Condylomata Acuminata 1Acquired Immunodeficiency Syndrome 1

Interventions

Human Papillomavirus Recombinant Vaccine Quadrivalent, Types 6, 11, 16, 18 11Vaccines, Synthetic 8Papillomavirus Vaccines 7Vaccines 4human papillomavirus vaccine, L1 type 16, 18 2Duration of Therapy 2Human Papillomavirus Recombinant Vaccine nonavalent 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Condylomata Acuminata × Human Papillomavirus Recombinant Vaccine nonavalent × Gynecologic × Clear all
NCT06681636 2024-11-08

HPV9vxFSW

National Institute of Hygiene and Epidemiology, Vietnam

Phase 2 Not yet recruiting
300 enrolled
Gynecologic

Uterine Cervical Neoplasms, Condylomata Acuminata, Papillomavirus Infections

Data powered by HemOnc (CC BY 4.0) Colophon âš¡